Qiangqiang Gu

Mayo Clinic, Mayo Clinic in Arizona

Papers

2

Total Citations

20

H-Index

2

About

Dr. Qiangqiang Gu is a pioneering researcher at the intersection of artificial intelligence and cerebrovascular disease, with a primary focus on aneurysmal subarachnoid hemorrhage (SAH)—a devastating stroke subtype carrying a 40% thirty-day mortality rate. His landmark 2023 work, "Artificial Intelligence and Machine Learning in Aneurysmal Subarachnoid Hemorrhage: Future Promises, Perils, and Practicalities," has already garnered 17 citations, establishing him as a leading voice in this emerging field. Dr. Gu’s major contribution lies in systematically evaluating how AI and machine learning can transform SAH management—from early detection and risk stratification to outcome prediction—while critically addressing the practical challenges of clinical integration. He argues compellingly that SAH patients desperately need an integrated AI system capable of synthesizing complex multimodal data to guide real-time decision-making. By mapping both the extraordinary potential and the very real perils of these technologies, Dr. Gu provides an essential roadmap for clinicians and researchers navigating this rapidly evolving landscape. His work bridges the gap between computational innovation and critical care, offering a balanced, evidence-based perspective that is equally valuable to neurosurgeons, intensivists, and data scientists seeking to improve outcomes for one of neurology’s most challenging conditions.

Research Focus

Key Achievements

2
H-Index
2
Papers
20
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Artificial intelligence and machine learning in aneurysmal subarachnoid hemorrhage: Future promises, perils, and practicalities
17 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Mayo Clinic, Mayo Clinic in Arizona

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago